Overview

Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety of duloxetine and see what effects (good and bad) it has on the subject's binge eating disorder and comorbid depressive disorder (depression occurring with binge eating disorder) compared to placebo (inactive pill).
Phase:
Phase 4
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride